Physician profile
Indrani Naskar
NPI 1720216872
$2,821.83
in general payments reported to CMS, 2019-2025
17 companies · $310 in 2025
The $310 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $983 · 2020: $298 · 2021: $579 · 2022: $282 · 2023: $268 · 2024: $101 · 2025: $310.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $679.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $815.73 | 2021-2025 | |
| Neurocrine Biosciences, INC. | $344.37 | 2019-2025 | |
| Otsuka America Pharmaceutical, INC. | $338.88 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $297.53 | 2019-2021 | |
| Alkermes, INC. | $264.71 | 2019-2021 | |
| Indivior INC. | $118.97 | 2019-2025 | Sublocade |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $113.42 | 2021-2024 | Caplyta |
| Vanda Pharmaceuticals INC. | $108.83 | 2019-2025 | Fanapt |
| Janssen Pharmaceuticals, INC | $85.36 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $79.16 | 2019-2024 | Uzedy |
| Allergan, INC. | $63.80 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $44.58 | 2019 | |
| Avanir Pharmaceuticals, INC. | $37.52 | 2019-2020 | |
| Corium, LLC | $29.47 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $29.37 | 2025 | Cobenfy |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $26.94 | 2019 | |
| Eisai INC. | $23.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Indrani Naskar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.